Brisbane manufacturer Bioxyne delivered record quarterly revenue of A$17.2 million in Q2 FY26, a 21% increase on Q1 and a 112% life on the previous corresponding year.
Cash receipts reached a record $18.4m, up 149% on Q2 FY25, while net cash from operating activities was positive at $2.5m.
Article by Cannabiz – https://www.cannabiz.com.au/bioxyne-hits-record-quarterly-revenue/